Replies to post #281010 on NorthWest Biotherapeutics Inc (NWBO)

[hope4patients]

Strongly agree.

[sukus]

That 400% looks very good to me Senti. Will it look good in front of the regulators and FDA? My feelings said so.. Even it would look good beyond FDA. Exciting and cannot wait the moment when they finally announce the results.

[erik007tc]

Excellent!

[KIPK]

Agree Totally With Your Statement...

"And if that number is anywhere near 20% living to 5 years, they would know that DCVax-L has beat SOC by 400%, irregardless of which patients started in treatment and which patients started in control"...

And I Would Add That, The Issue With The Crossover/Control Arm Has Been The Main Reason For NWBO To Extend This Trial As Long As They Have....

There Might Be Also Significant Difference Between Patients (the Therapy Arm) Who Receive The Treatment Early On....VS...The Control (Cross-Over) Who Receive It Much Later....